risperidone has been researched along with Diseases in Twins in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Diseases in Twins: Disorders affecting TWINS, one or both, at any age.
Excerpt | Relevance | Reference |
---|---|---|
"The increasing recognition of Tourette's syndrome is probably responsible for the broadening range of symptom severities seen in clinic patients." | 2.39 | Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. ( Peterson, BS, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Markovic, J | 1 |
Plestic, S | 1 |
Kostic, J | 1 |
Peterson, BS | 1 |
1 review available for risperidone and Diseases in Twins
Article | Year |
---|---|
Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Child; Clozapine; Disease Progression; Diseas | 1996 |
1 other study available for risperidone and Diseases in Twins
Article | Year |
---|---|
Concordant response to pharmacotherapy in monozygotic twins with schizoaffective disorder.
Topics: Affect; Alopecia; Antipsychotic Agents; Diseases in Twins; Drug Therapy, Combination; Emotions; Huma | 2013 |